Extra-thymically induced T regulatory cell subsets: The optimal target for antigen-specific immunotherapy

Immunology

Volumn 145, Issue 2, 2015, Pages 171-181

  Verhagen, Johan ^a   Wegner, Anja ^a   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antigen specificity; Foxp3; Immunotherapy; Interleukin 10; Regulatory T cell

Indexed keywords

INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN;

ANTIGEN SPECIFIC IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; DRUG EFFICACY; EX VIVO STUDY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MOLECULAR STABILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; TARGET CELL; ANIMAL; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; HYPERSENSITIVITY; IMMUNOLOGY; PATHOLOGY; PROCEDURES;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERLEUKIN-10; T-LYMPHOCYTES, REGULATORY;

EID: 84929659892     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12458     Document Type: Article

References (108)

1. Gagliani N, Magnani CF, Huber S et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 2013; 19:739-46.
2. Burton BR, Britton GJ, Fang H et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat Commun 2014; 5:4741.
3. + T regulatory cells. J Immunol 2010; 184:3433-41.
4. + T regulatory cells". J Immunol 2010; 185:7129; author reply 30.
5. Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS One 2011; 6:e24226.
6. Yadav M, Louvet C, Davini D et al. Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med 2012; 209:1713-22 S1-19.
7. + T reg cells. J Exp Med 2012; 209:1723-42.
8. Abbas AK, Benoist C, Bluestone JA et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013; 14:307-8.
9. Shevach EM, Thornton AM. tTregs, pTregs, and iTregs: similarities and differences. Immunol Rev 2014; 259:88-102.
10. Bacchetta R, Bigler M, Touraine JL et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994; 179:493-502.
11. Cong Y, Weaver CT, Lazenby A, Elson CO. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 2002; 169:6112-9.
12. Akdis M, Verhagen J, Taylor A et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199:1567-75.
13. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008; 205:2887-98.
14. Arif S, Tree TI, Astill TP et al. Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J Clin Invest 2004; 113:451-63.
15. Tree TI, Lawson J, Edwards H, Skowera A, Arif S, Roep BO, Peakman M. Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression. Diabetes 2010; 59:1451-60.
16. Astier AL, Meiffren G, Freeman S, Hafler DA. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 2006; 116:3252-7.
17. Martinez-Forero I, Garcia-Munoz R, Martinez-Pasamar S et al. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur J Immunol 2008; 38:576-86.
18. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 2007; 204:239-43.
19. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-64.
20. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775-85.
21. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007; 204:1765-74.
22. Furusawa Y, Obata Y, Fukuda S et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504:446-50.
23. Arpaia N, Campbell C, Fan X et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504:451-5.
24. + regulatory T cells. J Immunol 2013; 190:4971-81.
25. + regulatory T cells in immune tolerance. Annu Rev Immunol 2012; 30:733-58.
26. Bettini ML, Pan F, Bettini M et al. Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 2012; 36:717-30.
27. Darce J, Rudra D, Li L et al. An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 2012; 36:731-41.
28. Verhagen J, Burton BR, Britton GJ, Shepard ER, Anderton SM, Wraith DC. Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis. PLoS One 2013; 8:e61334.
29. Gregori S, Goudy KS, Roncarolo MG. The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Front Immunol 2012; 3:30.
30. Chattopadhyay G, Shevach EM. Antigen-specific induced T regulatory cells impair dendritic cell function via an IL-10/MARCH1-dependent mechanism. J Immunol 2013; 191:5875-84.
31. Schmitt EG, Haribhai D, Williams JB et al. IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy. J Immunol 2012; 189:5638-48.
32. + Treg cells but IL-10 mediates their function in experimental autoimmune encephalomyelitis. PLoS One 2014; 9:e108023.
33. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol 2013; 4:129.
34. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J Immunol 2004; 172:5213-21.
35. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009; 10:1178-84.
36. Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR. Interleukin-10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine 2014; doi: 10.1016/j.cyto.2014.10.031.
37. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
38. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003; 421:388-92.
39. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603-16.
40. + regulatory T cells. Nat Immunol 2010; 11:846-53.
41. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181:2277-84.
42. + Treg cell conversion of naive T cells. Immunity 2009; 30:471-2; author reply 2-3.
43. hi cells. Immunity 2008; 29:758-70.
44. Moore C, Tejon G, Fuentes C et al. Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection. Eur J Immunol 2015; 45:452-63.
45. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008; 453:65-71.
46. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 2010; 185:3190-8.
47. + regulatory T cells. Proc Natl Acad Sci USA 2008; 105:9331-6.
48. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009; 206:3015-29.
49. Amarnath S, Mangus CW, Wang JC et al. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med 2011; 3:111ra20.
50. Chen X, Fosco D, Kline DE, Meng L, Nishi S, Savage PA, Kline J. PD-1 regulates extrathymic regulatory T-cell differentiation. Eur J Immunol 2014; 44:2603-16.
51. Ellestad KK, Thangavelu G, Ewen CL, Boon L, Anderson CC. PD-1 is not required for natural or peripherally induced regulatory T cells: severe autoimmunity despite normal production of regulatory T cells. Eur J Immunol 2014; 44:3560-72.
52. Hippen KL, Merkel SC, Schirm DK et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. Am J Transplant 2011; 11:1148-57.
53. + Treg cells. J Immunol Methods 2014; 414:58-64.
54. Wei F, Zhang Y, Zhao W, Yu X, Liu CJ. Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions. PLoS One 2014; 9:e112110.
55. Bereshchenko O, Coppo M, Bruscoli S et al. GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling. Cell Rep 2014; 7:464-75.
56. Mota C, Nunes-Silva V, Pires AR, Matoso P, Victorino RM, Sousa AE, Caramalho I. Delta-like 1-mediated notch signaling enhances the in vitro conversion of human memory CD4 T cells into FOXP3-expressing regulatory T cells. J Immunol 2014; 193:5854-62.
57. Cobbold SP, Adams E, Farquhar CA et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci USA 2009; 106:12055-60.
58. Pabbisetty SK, Rabacal W, Maseda D et al. KLF2 is a rate-limiting transcription factor that can be targeted to enhance regulatory T-cell production. Proc Natl Acad Sci USA 2014; 111:9579-84.
59. Neildez-Nguyen TM, Bigot J, Da Rocha S, Corre G, Boisgerault F, Paldi A, Galy A. Hypoxic culture conditions enhance the generation of regulatory T cells. Immunology 2014; 144:431-43.
60. Sarkar D, Biswas M, Liao G et al. Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia. Mol Ther Methods Clin Dev 2014; 1:14030.
61. + stem cells-reconstituted NOD-scid IL2rγnull mice. PLoS One 2014; 9:e90387.
62. + regulatory T cells. Clin Exp Immunol 2014; 178:253-61.
63. Rossetti M, Spreafico R, Saidin S et al. Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. J Immunol 2015; 194:113-24.
64. Asnagli H, Martire D, Belmonte N et al. Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis. Arthritis Res Ther 2014; 16:R115.
65. Takasato F, Morita R, Schichita T et al. Prevention of allogeneic cardiac graft rejection by transfer of ex vivo expanded antigen-specific regulatory T-cells. PLoS One 2014; 9:e87722.
66. Lin Y, Liu X, Shan B, Wu J, Sharma S, Sun Y. Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells. PLoS One 2014; 9:e94702.
67. + regulatory T lymphocytes through the induction of anergy and infectious tolerance. J Immunol 2008; 180:2830-8.
68. Zhang H, Podojil JR, Chang J, Luo X, Miller SD. TGF-β-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol 2010; 184:6629-36.
69. - T regulatory cells. Clin Immunol 2009; 133:22-6.
70. Brunstein CG, Miller JS, Cao Q et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011; 117:1061-70.
71. Di Ianni M, Falzetti F, Carotti A et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011; 117:3921-8.
72. Desreumaux P, Foussat A, Allez M et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 2012; 143:1207-17 e1-2.
73. Bacchetta R, Lucarelli B, Sartirana C et al. Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells. Front Immunol 2014; 5:16.
74. Sagoo P, Ali N, Garg G, Nestle FO, Lechler RI, Lombardi G. Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells. Sci Transl Med 2011; 3:83ra42.
75. Sabatos-Peyton CA, Verhagen J, Wraith DC. Antigen-specific immunotherapy of autoimmune and allergic diseases. Curr Opin Immunol 2010; 22:609-15.
76. Anderson RP, Jabri B. Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol 2013; 25:410-7.
77. + T regulatory cells. PLoS One 2014; 9:e112242.
78. Gabrysova L, Nicolson KS, Streeter HB, Verhagen J, Sabatos-Peyton CA, Morgan DJ, Wraith DC. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 2009; 206:1755-67.
79. + T cells. J Exp Med 2012; 209:109-21.
80. Getts DR, McCarthy DP, Miller SD. Exploiting apoptosis for therapeutic tolerance induction. J Immunol 2013; 191:5341-6.
81. Getts DR, Martin AJ, McCarthy DP et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol 2012; 30:1217-24.
82. Maldonado RA, LaMothe RA, Ferrari JD et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci USA 2015; 112:E156-65.
83. Gagliani N, Gregori S, Jofra T et al. Rapamycin combined with anti-CD45RB mAb and IL-10 or with G-CSF induces tolerance in a stringent mouse model of islet transplantation. PLoS One 2011; 6:e28434.
84. Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J Exp Med 2004; 199:1401-8.
85. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005; 6:1219-27.
86. Molinero LL, Miller ML, Evaristo C, Alegre ML. High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner. J Immunol 2011; 186:4609-17.
87. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005; 115:1923-33.
88. Luth S, Huber S, Schramm C et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008; 118:3403-10.
89. + Tregs by liver sinusoidal endothelial cells. J Hepatol 2014; 61:594-9.
90. Kasagi S, Zhang P, Che L et al. In vivo-generated antigen-specific regulatory T cells treat autoimmunity without compromising antibacterial immune response. Sci Transl Med 2014; 6:241ra78.
91. Bailey-Bucktrout SL, Martinez-Llordella M, Zhou X et al. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 2013; 39:949-62.
92. Laurence A, Amarnath S, Mariotti J et al. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity 2012; 37:209-22.
93. Nie H, Zheng Y, Li R et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med 2013; 19:322-8.
94. + T cells into TH17 cells in autoimmune arthritis. Nat Med 2014; 20:62-8.
95. + regulatory T. cell phenotype in the inflammatory environment. J Immunol 2013; 190:1076-84.
96. + Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production. Eur J Immunol 2012; 42:1174-9.
97. Reynolds BC, Turner DG, McPherson RC et al. Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells. Eur J Immunol 2014; 44:3342-52.
98. O'Connor RA, Leech MD, Suffner J, Hammerling GJ, Anderton SM. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J Immunol 2010; 185:7235-43.
99. + regulatory T cells in human autoimmune disease. Nat Med 2011; 17:673-5.
100. + regulatory T cells. Immunol Rev 2014; 259:159-72.
101. Daniel C, Weigmann B, Bronson R, von Boehmer H. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope. J Exp Med 2011; 208:1501-10.
102. Martin B, Auffray C, Delpoux A et al. Highly self-reactive naive CD4 T cells are prone to differentiate into regulatory T cells. Nat Commun 2013; 4:2209.
103. Gabrysova L, Wraith DC. Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur J Immunol 2010; 40:1386-95.
104. Bielekova B, Goodwin B, Richert N et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 2000; 6:1167-75.
105. Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The altered peptide ligand in relapsing MS Study Group. Nat Med 2000; 6:1176-82.
106. + regulatory T cells in humans and mice. Immunol Cell Biol 2014; 92:659-70.
107. Gagliani N, Jofra T, Valle A et al. Transplant tolerance to pancreatic islets is initiated in the graft and sustained in the spleen. Am J Transplant 2013; 13:1963-75.
108. Thome JJ, Yudanin N, Ohmura Y et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 2014; 159:814-28.